mci 9038 and warfarin
mci 9038 has been researched along with warfarin in 66 studies
Research
Studies (66)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (9.09) | 18.2507 |
2000's | 38 (57.58) | 29.6817 |
2010's | 19 (28.79) | 24.3611 |
2020's | 3 (4.55) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X | 1 |
Loscalzo, J; Scharfstein, J | 1 |
Funahara, Y; Hijikata-Okunomiya, A; Opartkiattikul, N | 1 |
Fareed, J; Hoppensteadt, DA; Kahn, S | 1 |
Becker, JC; Hursting, MJ; Joffrion, JL; Knappenberger, GD; Schwarz, RP; Zehnder, JL | 1 |
Jang, IK; Januzzi, JL | 1 |
Armstrong, PW; Choy, JB | 1 |
Ataullakhanov, FI; Krasotkina, YV; Sinauridze, EI | 1 |
DiCicco, RA; Hursting, MJ; Jorkasky, DK; Montague, T; Sheth, SB | 1 |
Bode, C; Darius, H; Diehm, C; Encke, A; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schrör, T; Schulte, KL; Tebbe, U; Van Aken, H | 1 |
Cho, JH; Dan, T; Kim, HY; Koga, T; Koo, BA; Seo, HS; Yun, CH | 1 |
Gordan, L; Gorman, R; Kitchens, C; Zumberg, M | 1 |
Warkentin, TE | 3 |
Smythe, MA; Warkentin, TE | 1 |
Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D | 1 |
Brown, PM; Hursting, MJ | 1 |
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R | 1 |
Fritsma, GA | 1 |
Shinohara, Y | 1 |
White, CM | 1 |
Bartholomew, JR | 1 |
Arpino, PA; Demirjian, Z; Van Cott, EM | 1 |
Hursting, MJ; Lewis, BE; Macfarlane, DE | 1 |
Bartholomew, JR; Hursting, MJ | 1 |
Rice, L | 1 |
Charest, AF; Geerts, WH; Grand'Maison, A | 1 |
Dager, W; Spinler, SA | 1 |
Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL | 1 |
Durr, EA; Krueger, CD; Shapiro, NL | 1 |
Hirata, K; Iwanami, H; Odaka, M | 1 |
Kloecker, GH; Laber, DA; Martin, ME | 1 |
Ahmed, I; Majeed, A; Powell, R | 1 |
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J | 1 |
Allen, SL; Barginear, MF; Bhaskaran, M; Bradley, T; Budman, DR; Donahue, L; Shapira, I | 1 |
Diez-Ewald, M | 1 |
Taimeh, Z; Weksler, B | 1 |
Chong, BH; Isaacs, A | 1 |
Maldonado, A | 1 |
Bara, C; Gras, C; Hafer, C; Haverich, A; Kuehn, C; Malehsa, D; Meyer, AL; Strüber, M | 1 |
Ichinoe, M; Mikami, T; Okayasu, I; Suzuki, K; Ujiie, S | 1 |
Ortel, TL | 1 |
Castellone, DD; Van Cott, EM | 1 |
Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D | 1 |
Jain, PG; Kauflin, MJ; Nanda, MM; Yannetta, JC | 1 |
Becher, T; Berdel, P; Braunstein, J; Gravius, S; Mayer, G; Müller, J; Oldenburg, J; Pötzsch, B; Rohrbach, F | 1 |
Young, G | 2 |
Austin, JH; Paciullo, CA; Stearns, CR; Winkler, AM | 1 |
Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
Azuma, S; Lum, CJ | 1 |
Burger, CF; Schlesinger, JJ | 1 |
Fabris, F; Furian, L; Nordio, M; Treleani, M; Vianello, F | 1 |
Kadauke, S; Khor, B; Van Cott, EM | 1 |
Ito, S; McAlister, RK | 1 |
Gates, C; Neave, L; Scully, M | 1 |
Male, C; van Ommen, CH; Young, G | 1 |
Abramov, D; Birks, E; Bitar, A; Lenneman, A; Massey, T; Slaughter, M; Vijayakrishnan, R | 1 |
Boivin, G; Checkmahomed, L; Couture, C; Hamelin, MÈ; Jandrot-Perrus, M; Lê, BV; Venable, MC | 1 |
Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN | 1 |
Chapman, K; Makhija, K; Prasad, R | 1 |
Reviews
24 review(s) available for mci 9038 and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis | 2022 |
Molecular approaches to antithrombotic therapy.
Topics: Amino Acid Chloromethyl Ketones; Antithrombins; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Protease Inhibitors; Sulfonamides; Thrombin; Warfarin | 1992 |
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 1999 |
Anticoagulant therapy in unstable angina.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Warfarin | 1999 |
Anticoagulation: the present and future.
Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzylamines; Binding Sites; Biological Availability; Blood Coagulation; Comorbidity; Coumarins; Drug Design; Embolism; Female; Forecasting; Glycine; Guanidines; Heart Diseases; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Neoplasms; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Safety; Serine; Stroke; Sulfonamides; Thrombin; Thrombophilia; Thrombosis | 2001 |
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin | 2002 |
Direct thrombin inhibitors.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2004 |
Heparin-induced thrombocytopenia: diagnosis and management.
Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin | 2004 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Thrombin-directed inhibitors: pharmacology and clinical use.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2005 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Evolving management strategies for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin | 2005 |
Anticoagulant use in patients with chronic renal impairment.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudins; Humans; Kidney Failure, Chronic; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Warfarin | 2005 |
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin | 2006 |
Argatroban for anticoagulation during cardiac surgery.
Topics: Adult; Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Monitoring; Endocarditis, Bacterial; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Subclavian Vein; Sulfonamides; Thrombosis; Venous Thrombosis; Warfarin; Whole Blood Coagulation Time | 2007 |
Heparin induced thrombocytopenia: diagnosis and management update.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2007 |
Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2010 |
Heparin-induced thrombocytopenia: what clinicians need to know.
Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2009 |
Laboratory monitoring of new anticoagulants.
Topics: Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Chromogenic Compounds; Drug Monitoring; Factor Xa Inhibitors; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Warfarin | 2010 |
Old and new antithrombotic drugs in neonates and infants.
Topics: Anticoagulants; Arginine; Fondaparinux; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infant; Infant, Newborn; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Venous Thromboembolism; Warfarin | 2011 |
Anticoagulants in children and adolescents.
Topics: Adolescent; Anticoagulants; Arginine; Child; Clinical Trials as Topic; Fondaparinux; Hematology; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Treatment Outcome; Warfarin | 2015 |
How we manage patients with heparin induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Disease Management; Fondaparinux; Heparin; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Warfarin | 2016 |
Trials
5 trial(s) available for mci 9038 and warfarin
Article | Year |
---|---|
Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
Topics: Adult; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor X; Hemostatics; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thromboplastin; Warfarin | 2001 |
Lack of pharmacokinetic interactions between argatroban and warfarin.
Topics: Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Arginine; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pipecolic Acids; Sulfonamides; Warfarin | 2002 |
Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Factor X; Female; Hospitals, University; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Prospective Studies; ROC Curve; Sulfonamides; Warfarin | 2005 |
Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Infusions, Intravenous; International Normalized Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2005 |
Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Topics: Adult; Aged; Amputation, Surgical; Arginine; Cause of Death; Female; Hemorrhage; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Assessment; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin | 2005 |
Other Studies
37 other study(ies) available for mci 9038 and warfarin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
Topics: Adolescent; Adult; Antithrombins; Arginine; Benzamidines; Blood Coagulation Tests; Dipeptides; Guanidines; Humans; Pipecolic Acids; Prothrombin; Sulfonamides; Warfarin | 1991 |
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Drug Monitoring; Drug Therapy, Combination; Factor X; False Positive Reactions; Female; Heparin; Humans; Indicators and Reagents; Male; Pipecolic Acids; Prothrombin Time; Reference Values; Reproducibility of Results; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 1997 |
The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used.
Topics: Anticoagulants; Arginine; Humans; International Normalized Ratio; Pipecolic Acids; Prothrombin Time; Sulfonamides; Thromboplastin; Warfarin | 1999 |
Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion.
Topics: alpha-Macroglobulins; Antithrombins; Arginine; Blood Coagulation; Calcium; Coumarins; Diffusion; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Kinetics; Models, Theoretical; Pipecolic Acids; Plasma; Solutions; Sulfonamides; Thrombin | 2000 |
The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
Topics: Administration, Oral; Amidines; Animals; Arginine; Azepines; Bleeding Time; Carotid Artery Thrombosis; Dalteparin; Drug Evaluation, Preclinical; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Molecular Structure; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin; Vena Cava, Inferior; Venous Thrombosis; Warfarin | 2001 |
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin | 2001 |
Comment: treatment of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2002 |
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin | 2002 |
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin | 2002 |
Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.
Topics: Aged; Anticoagulants; Arginine; Humans; International Normalized Ratio; Kidney; Kidney Function Tests; Liver; Lung Neoplasms; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Venous Thrombosis; Warfarin | 2005 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
[Bilateral cerebellar infarction caused by intracranial dissection of the vertebral artery after long periods of "Shiatsu"].
Topics: Acupressure; Acute Disease; Angiography; Anticoagulants; Arginine; Cerebellum; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Female; Humans; Infusions, Intravenous; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Vertebral Artery Dissection; Warfarin | 2007 |
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2008 |
Heparin-induced thrombocytopenia complicating hemodialysis.
Topics: Adult; Anticoagulants; Arginine; Calciphylaxis; Drug Contamination; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Skin Diseases; Sulfonamides; Thrombocytopenia; Warfarin | 2008 |
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin | 2008 |
[Are new anticoagulants better?].
Topics: Anticoagulants; Arginine; Drugs, Investigational; Factor Xa Inhibitors; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2007 |
Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.
Topics: Aged; Antibodies, Anticardiolipin; Anticoagulants; Arginine; Catheterization; Contraindications; Drug Therapy, Combination; Femoral Vein; Heparin; Humans; Iliac Vein; Infusions, Intravenous; Ischemia; Kidney; Kidney Transplantation; Male; Pipecolic Acids; Popliteal Vein; Postoperative Complications; Protein S Deficiency; Purpura, Thrombocytopenic, Idiopathic; Renal Veins; Sulfonamides; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator; Vena Cava Filters; Venous Thrombosis; Warfarin | 2009 |
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Iloprost; Length of Stay; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Warfarin | 2009 |
Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up.
Topics: Aged; Anticoagulants; Arginine; Embolism, Cholesterol; Fatal Outcome; Heparin; Humans; Male; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin | 2011 |
Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Topics: Aged; Anticoagulants; Arginine; Atrial Fibrillation; Blood Coagulation Tests; Carotid Stenosis; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Warfarin | 2011 |
Profiling of active thrombin in human blood by supramolecular complexes.
Topics: Aptamers, Nucleotide; Arginine; Binding Sites; Blood Coagulation; Coumarins; Enzyme Assays; Humans; Limit of Detection; Peptides; Pipecolic Acids; Sensitivity and Specificity; Sulfonamides; Thrombin | 2011 |
Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
Topics: Academic Medical Centers; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Databases, Factual; Drug Administration Schedule; Electronic Health Records; Factor X; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sulfonamides; Warfarin | 2012 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
A comparison of methods for estimating glomerular filtration rate for a population in Hawai'i with non-valvular atrial fibrillation.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Glomerular Filtration Rate; Hawaii; Humans; Male; Morpholines; Pipecolic Acids; Retrospective Studies; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2013 |
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2014 |
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Polycystic Kidney Diseases; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2015 |
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2014 |
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin | 2015 |
Anticoagulation in children: Making the most of little patients and little evidence.
Topics: Anticoagulants; Arginine; Blood Coagulation; Child; Drug Monitoring; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombosis; Venous Thromboembolism; Warfarin | 2017 |
The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
Topics: Adult; Aged; Anticoagulants; Arginine; Eptifibatide; Female; Heart Failure; Heart-Assist Devices; Hemolysis; Heparin; Humans; Male; Middle Aged; Peptides; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombosis; Warfarin; Young Adult | 2017 |
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.
Topics: Animals; Anticoagulants; Arginine; Disease Models, Animal; Heparin; Metapneumovirus; Mice; Paramyxoviridae Infections; Pipecolic Acids; Sulfonamides; Survival Analysis; Treatment Outcome; Viral Load; Virus Replication; Warfarin | 2018 |
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin | 2020 |
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
Topics: Aged; Anticoagulants; Arginine; Heparin; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Warfarin | 2021 |